The Prazepam Capsules, cataloged under National Stock Number 6505-01-159-6941, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 3 specifications, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-159-6941 |
| Item Name | Prazepam Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 500.0 |
| Active Medicament Medicinal Strength | 10.0 MILLIGRAMS PRAZEPAM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| NDC00071-0553-30 | 3/9 Design control — primary reference U.S. Government activity |
| CENTRAX | 5/1 Secondary reference U.S. Government activity |
| CENTRAX CAPSULES | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-159-6941 is a Prazepam Capsules, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-159-6941: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 500.0; Active Medicament Medicinal Strength: 10.0 MILLIGRAMS PRAZEPAM ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.